Dr. Kehl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3468
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2012 - 2026
- NH State Medical License 2024 - 2024
- TX State Medical License 2014 - 2019
- IL State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 35 citationsDiscussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal CancerKenneth L. Kehl, Neeraj Arora, Deborah Schrag, John Z. Ayanian, Steven B. Clauser
Journal of the National Cancer Institute. 2014-10-01 - 2 citationsEnhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes ...Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu
Journal of Clinical Oncology. 2024-09-03 - 100 citationsAnalysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.Ino de Bruijn, Ritika Kundra, Brooke Mastrogiacomo, Thinh Ngoc Tran, Luke Sikina
Cancer Research. 2023-12-01
Press Mentions
- Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
- Lack of Guideline-Concordant Treatment for Early-Stage Non-Small Cell Lung Cancer CommonMay 13th, 2022
- ‘More Effort Needed’ to Optimize Use of Standard Early NSCLC TherapiesMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: